Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Multiple Sclerosis

Biogen reports sales jump, backs tolerability of new MS pill

April 25, 2013

Execs unveiled 10% sales growth and told investors the safety news does not implicate their just-approved MS pill.
 

Business Briefs: Docs question Gleevec price, Sanofi pill may delay MS onset

April 25, 2013

Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
 

MS patients hungry for info on orals, says survey

March 14, 2013

MS patients have an "insatiable appetite" for information about treatments online, particularly the new class of oral treatments, whose manufacturers could be doing more to prep them for switch conversations, a survey suggests.
 

Biogen brags of Phase III data for would-be Aubagio rival oral MS drug

September 20, 2012

A study in the New England Journal of Medicine said patients had a significant relapse reduction over two years on the oral drug.
 

FDA approves Sanofi daily MS pill

September 13, 2012

The move expands patient options, but industry watchers tell MM&M it's not going to spur a radical change in treatment.
 

Company news: Medivation/Astellas and Teva

August 08, 2012

A cancer drug being developed by Medivation and Astellas gets its closeup, and Teva launches in to Phase III trials of its oral MS drug laquinimod.
 

Genzyme-backed program to chronicle lives of patients with MS

August 02, 2012

Five patients will document their challenges and triumphs online in this project developed by the National MS Society and Sanofi's Genzyme unit.
 

Tysabri gets boost from label change, new diagnostic

, Marc Iskowitz January 23, 2012

Biogen Idec and Elan, which market Tysabri for multiple sclerosis, won approval to add new safety information to the drug's label that could boost sales by helping doctors avoid a serious adverse event.
 
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising App Approval Centers For Disease Control Clinical Trial Consumer COPD Corporate Reputation Device Diabetes DTC Earnings Elan FDA Generic Generic Drugs iPad Marketing & Communications Mobile Obesity Patients Regulatory Wellness